Fore Biotherapeutics raises $75M to advance potential cancer therapy, announces CEO departure


Philadelphia-based Fore Biotherapeutics has now raised $166 million in funding.

Previous Austin developers undergo training to build more affordable housing
Next Bailey Bug founder gears up for appearance on startup show 'The Blox'